Preparation, characterization and nasal delivery of α-cobrotoxin-loaded poly(lactide- co-glycolide)/polyanhydride microspheres

In this study, α-cobrotoxin was incorporated into the microspheres composed of poly(lactide- co-glycolide) (PLGA) and poly[1,3-bis( p-carboxy-phenoxy) propane- co– p-(carboxyethylformamido) benzoic anhydride] (P(CPP:CEFB)) and intranasally delivered to model rats in order to improve its analgesic activity. The microspheres with high entrapment efficiency (> 80%) and average diameter of about 25 μm could be prepared by a modified water-in-oil-in-oil (w/o/o) emulsion solvent evaporation method. Scanning electron micrograph (SEM) study indicated that P(CPP:CEFB) content played a considerable role on the morphology and degradation of the microspheres. The presence of P(CPP:CEFB) in the microspheres increased their residence time at the surface of the nasal rat mucosa. The toxicity of the composite microspheres to nasal mucosa was proved to be mild and reversible. A tail flick assay was used to evaluate the antinociceptive activity of the microspheres after nasal administration. Compared with the free α-cobrotoxin and PLGA microspheres, PLGA/P(CPP:CEFB) microspheres showed an apparent increase in the strength and duration of the antinociceptive effect at the same dose of α-cobrotoxin (80 μg/kg body weight).